Maria T. Mejia created a video to get the message out that undetectable equals untransmittable, saying "we need to be visible and we need to reach main stream media."
"What haunts me the most are my memories of being a volunteer HIV testing counselor in the late 1980s and early 1990s," writes Richard Wolitski, Ph.D., as he reflects on this year's World AIDS Day.
Why do Americans and their insurers pay more for some drugs and less for others? And who decides what a fair price for a drug should be, and how can manufacturers and health plans be compelled to improve access and affordability?
After Larry Kramer received a lifetime achievement award from GMHC, his comments bristled some in the HIV/AIDS community. Steve Helmke of ACT UP has a response to Kramer's comments.
What would you be willing to pay for a cure for HIV? We bring you five fresh perspectives, from science to the streets.
With a new lease on life -- and new ways to strengthen her memory in the midst of HIV-related dementia -- blogger Lynda Arnold has a lot to be thankful for.
"I realized that we only get one life -- one pass through -- and God, it has to count." Blogger Lynda Arnold shares lessons from a long, frightening period of health challenges.
Are those with undetectable viral loads still laboring under the burden of being seen as being as infectious as ever? What's the potential of that message to cause harm?
"I accept that it will take some time for the general population to catch up with the news that undetectable people can't pass on the virus," an incensed Dave R. writes in his latest blog; "but I hate the fact that nobody is interested in publicizing...
First, they were diagnosed. Then, they started treatment. Then, they advocated for others. In this roundtable, three treatment activists discuss their journeys.